Clinical application for a new radial artery hemostatic device: a prospective, randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025140

Enrollment

Unknown

Registered

2019-08-13

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial annulation

Interventions

experimental group :Hemostatic device

control group:Conventional compression

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective general surgeries wiht radial artery catheterization in West China Hospital. 2. Aged 18 to 80 years. 3. ASA 1-3.

Exclusion criteria

Exclusion criteria: 1. Subjects who could not cooperate with the study for any reason. 2. Patients with impaired communications due to language and consciousness disorders. 3. Patients with severe blood coagulation dysfunctions. 4. Pre-existed nerve injury, featured as numbness, paraesthesia or muscle weakness, in the puncture/annulation arm. 5. Delayed extubation cases, like patients transferring to ICU where prolonged annulation were needed.

Design outcomes

Primary

Measure	Time frame
Incidence of puncture-related complications within 30 days after operation;	—

Countries

China

Contacts

Public ContactYunxia Zuo

West China Hospital of Sichuan University

769574913@qq.com+86 18980601541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026